This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

Brain_Navi_Biotechnology unveils NaoTrac neurosurgical robot

Analysis based on 6 articles · First reported May 26, 2026 · Last updated May 26, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The introduction of NaoTrac>>> by Brain Navi Biotechnology>>> is expected to positively impact the medical device and healthcare industries by improving surgical outcomes and efficiency. This innovation could lead to increased adoption of robotic surgical systems, benefiting companies in this sector.

Medical Devices Healthcare Biotechnology

Brain Navi Biotechnology>>> has developed NaoTrac>>>, a neurosurgical navigational robot designed to revolutionize brain surgery. This technology enhances precision, reduces surgical time from 49.1 minutes to 2.4 minutes, and simplifies the learning curve for surgeons by utilizing machine vision and 3D positioning to detect facial checkpoints without invasive head frames. NaoTrac>>> operates with a 'semi-autonomous' model, ensuring stability and precision while allowing surgeons to maintain professional judgment. The system has received global approvals from regulatory bodies like TFDA, CE, United States — Food and Drug Administration>>>, and India — Central Drugs Standard Control Organisation>>>, underscoring its world-class quality. Dr. Jerry Chieh Hsiao Chen, CEO of Brain Navi Biotechnology>>>, spearheaded this innovation, aiming to make surgery more precise and improve patient lives. The technology represents a significant advancement in minimally invasive neurosurgery, transforming Taiwanese ingenuity into a global force for health.

priv
Brain Navi Biotechnology developed NaoTrac, a neurosurgical navigational robot, which is transforming neurosurgery with enhanced precision and efficiency. This innovation positions the company as a leader in medical technology.
Importance 100.0 Sentiment 80.0
oth
NaoTrac is a neurosurgical navigational robot developed by Brain Navi Biotechnology>>> that significantly improves precision, reduces surgical time, and flattens the learning curve for surgeons, leading to better patient outcomes.
Importance 100.0 Sentiment 85.0
per
Dr. Jerry Chieh Hsiao Chen is the CEO of Brain Navi Biotechnology>>> and has led the development of NaoTrac>>> over ten years, bridging biomedical engineering with clinical needs.
Importance 70.0 Sentiment 70.0
cnt
Taiwan is highlighted as the origin of the ingenuity behind NaoTrac>>>, showcasing its contribution to global health innovation.
Importance 30.0 Sentiment 20.0
govactor
The India — Central Drugs Standard Control Organisation>>> has approved NaoTrac>>>, signifying its acceptance and quality for use in India.
Importance 20.0 Sentiment 0.0
govactor
The United States — Food and Drug Administration>>> is one of the regulatory bodies that has approved NaoTrac>>>, indicating its safety and quality for use in the United States.
Importance 20.0 Sentiment 0.0
per
Ehab Shiban is mentioned as a user of NaoTrac>>> for brain surgery navigation, demonstrating its practical application by medical professionals.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.